Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva
Abstract
No abstract availableKeywords
Funding Information
- Fondazione Telethon (GGP15196)
This publication has 26 references indexed in Scilit:
- An investigation of BMP-7 mediated alterations to BMP signalling components in human tenocyte-like cellsScientific Reports, 2016
- Bone Morphogenetic ProteinsCold Spring Harbor Perspectives in Biology, 2016
- Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disordersCytokine & Growth Factor Reviews, 2016
- Neofunction of ACVR1 in fibrodysplasia ossificans progressivaProceedings of the National Academy of Sciences, 2015
- ACVR1
R206H
receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin AScience Translational Medicine, 2015
- Identification and characterization of regulatory elements in the promoter of ACVR1, the gene mutated in Fibrodysplasia Ossificans ProgressivaOrphanet Journal of Rare Diseases, 2013
- Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonistsNature Medicine, 2011
- Fibrodysplasia Ossificans Progressiva: Clinical and Genetic AspectsOrphanet Journal of Rare Diseases, 2011
- A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressivaNature Genetics, 2006
- Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 PromoterJournal of Biological Chemistry, 2002